Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...

The Series B funds will support the launch of a Phase I/II clinical trial for AIR-001 to advance its RNA editing pipeline.

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

Scientists at Oak Ridge National Laboratory have developed the first-ever method of detecting ribonucleic acid, or RNA, ...

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a disease targeted by several other firms.

The genetic code acts as life’s instruction manual, telling cells how to build proteins from DNA and RNA. Though it's a ...

AIRNA, a transatlantic RNA editing biotech, is prepping to launch its lead asset into clinical trials with fuel from a $155 ...

When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...

New precision genome editing technologies are transforming the therapeutic landscape for patients with certain cancers and ...

Viruses known as “jumbo phage” are a new hope against the rising antibacterial infection crisis. Researchers have discovered ...

A collaborative effort between The Wistar Institute, University of Pennsylvania, and INOVIO Pharmaceuticals has led to an ...